Nantes University Hospital: Melanoma trials

The registry lists 11 Melanoma studies with Nantes University Hospital as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 1 4Phase 2 4Phase 3 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• COmparison of the Use of a PERforator Flap Versus Total Skin GRAft in the Management of Loss of Substance After Resection of Cutaneous Melanoma - Pilot StudyRecruitingNCT07354152
• Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Predictive Factor of Response to Anti-PD-1RecruitingNCT05856565
• French Clinical Datbase of Melanoma Patients (RIC-Mel)RecruitingNCT03315468
• Medico-economic Evaluation Comparing the Impact of the New Fixed-dose Nivolumab Regimen With the Old mg/kg Regimen in the Management of Patients With Metastatic CancerCompletedNCT05380336
• Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma PatientsStatus unknownNCT03374839Phase 1/2
• Post-ATU Study of NivolumabCompletedNCT03325257
• Adoptive Transfer of Specific Melanoma Antigens CD8+ T Cells in Metastatic Melanoma Patients: a Phase I/II StudyCompletedNCT02424916Phase 1/2
• COPARIME: Pilot Study of a Target Detection of Malignant MelanomaCompletedNCT01610531Not applicable
• A Study of Immunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg)TerminatedNCT01082887Phase 1/2
• Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL ClonesCompletedNCT00720031Phase 1/2
• Tumor Infiltrating Lymphocytes Adjuvant Therapy of MelanomaCompletedNCT00200577Phase 3